Journal of Neurosurgery
 
Journal of Neurosurgery: Spine
 
Journal of Neurosurgery: Pediatrics
 
Neurosurgical Focus
July 2008 Volume 25, Number 1
Ablative neurosurgery for mental disorders: is there still a role in the 21st century? A personal perspective
M. Sam Eljamel, M.D., F.R.C.S.(Ire), F.R.C.S.(Edin), F.R.C.S.(Sn)
Department of Neurosurgery, Ninewells Hospital and Medical School, Dundee, Scotland, United Kingdom
Address correspondence to: M. Sam Eljamel, M.D., Department of Neurosurgery, Ninewells Hospital & Medical School, Dundee DD1 9SY, Scotland, United Kingdom. email: .

DOI: 10.3171/FOC/2008/25/7/E4

Figures and Tables

Abstract
Object

The author presents his personal perspective on ablative neurosurgical techniques used to perform bilateral anterior cingulotomy (BACI) and bilateral anterior capsulotomy (BACA) for ameliorating the symptoms of refractory obsessive-compulsive disorder (OCD) and treatment refractory depression (TRD). With depression predicted to be the second most common cause of disability in the world by the year 2020 and the birth of electric neurostimulation representing an attractive alternative treatment option for TRD and OCD, it is desirable to revisit the pros and cons of these treatment options.

Methods

The author reviewed the surgical methods and outcome (including neuroimaging findings) in all cases in which ablative neurosurgery was performed at Ninewells Hospital and Medical School over the last 2 decades.

Results

The advantages of ablative procedures (BACI and BACA) from patients’ and psychiatrists’ perspectives are that the ablative procedures are one-off procedures that do not require lifelong commitment to program the stimulation devices, fix hardware failures, or change exhausted batteries. From the perspective of healthcare funding bodies, the relatively low cost of these treatments is an advantage. The main disadvantages of BACI and BACA are the perceived higher complication rates, the irreversibility of the surgical lesions, and the stigma associated with brain destruction in psychiatric patients that are still unpalatable in the community at large. However, some patients still choose a one-off procedure in preference to any other options presented to them.

Conclusions

There is still place for BACI and BACA in modern neurosurgery for mental disorders, at least in the short term for those who do not want to commit to lifelong device programming and maintenance.

Keywords: ablation; capsulotomy; cingulotomy; depression; obsessive-compulsive disorder. Abbreviations used in this paper: BACA = bilateral anterior capsulotomy; BACI = bilateral anterior cingulotomy; DBS = deep brain stimulation; ECT = electroconvulsive therapy; HRSD = Hamilton Rating Scale for Depression; HRSD-17 = 17-item HRSD; OCD = obsessive-compulsive disorder; TRD = treatment refractory depression; VNS = vagus nerve stimulation.


Introduction

The anterior cingulate gyrus has been thought to be involved in emotion rostrally, motion caudally, and cognition and experience of pain in the middle.6,14,31-33,36 It consists of the cingulate cortex and the cingulum bundle that runs parallel to the cingulate cortex and projects to the striatum and the thalamus.5,25 Functional imaging of the brains of healthy volunteers and depressed patients supports the observed effects of BACI in TRD. Functional imaging of depressed patients demonstrated that the rostral part of the cingulate cortex was the most likely part of the cingulate gyrus to be involved in depression.9,31 Although BACI has been used for the treatment of TRD, OCD, and other psychiatric illnesses for many years, the exact location of the target is not clear, making comparative analysis of the results from different series difficult.

In this paper the ablative surgical procedures performed in the Department of Neurosurgery at Ninewells Hospital and Medical School over the last 2 decades are summarized and the issues surrounding the choices made by patients to treat their mental illness are discussed. Over the past 10 years, I have used the surgical techniques presented here with little variation. Nevertheless the size and location of the resultant lesions varied from patient to patient on long-term postoperative MR image analysis.31 These inevitable variations make the interpretation of the clinical outcome even more difficult. There are several reasons for this imprecision of the target: 1) Distortion occurs in MR imaging due to continuous pulsations of the living human brain within the skull and image transformation during coordinate calculations. This inherent error can be as high as 5–8 mm in the vertical axis.2,11,13 2) Mechanical errors in framering position relative to the skull introduce tilt, yaw, and rotation, and manual frame adjustments must be made to translate the calculated coordinates to the aiming-bow of the stereotactic frame.10,13,21 3) Brain shift may be introduced by the change of head position on the operating table compared to the head position during the scan as well as by cerebrospinal fluid escape and air entry during electrode insertion through the dura mater.10,11,13


Methods

This is a retrospective review of ablative procedures for mental disorders performed in Dundee with emphasis on the surgical technique. The sources of information included operative notes, operating room logbooks, feedback from psychiatrists about the 12-month outcome, intraoperative data collection, and postoperative neuroimaging studies performed within 1 week of surgery and 12 months after surgery.

Bilateral Anterior Cingulotomy
Patient Selection

Patients were selected for the procedure according to the inclusion and exclusion criteria summarized in Table 1. At the beginning of the series BACI was the preferred second choice, but as experience was gained and results accumulated, BACI became the first choice for TRD.


TABLE 1 Inclusion and exclusion criteria for neurosurgery for mental disorders in Ninewells Hospital and Medical School*

Preparation and Planning

General anesthesia was induced using intravenous anesthetic agents. The Zamorano-Dujovny stereotactic frame reference ring was applied in a plane parallel to the glabellainion line symmetrically to avoid tilt, yaw, and rotation of the head in relation to the stereotactic frame localizer. Surface fiducial markers were placed on the forehead and 1.5 cm on either side of the mid-line in front of the coronal suture to mark the entry points (Fig. 1).



View larger version (27K)

Fig. 1 Photograph showing the external skin markers used in BACI and BACA.



The patient’s head was fixed to the CT table so that the frame angles were 0°. This was achieved by making sure that the stereotactic frame localizer was at the center of the gantry using the scanner’s laser light alignment system and a water level. A volumetric contiguous axial CT scan was obtained parallel to the stereotactic frame reference ring, and DICOM images were transferred to the workstation where the frame-link software (Medtronic Sofamor Danek) was available to plan the procedure. The patient was then transferred to a 1.5-T MR imaging unit, and volumetric MP-RAGE (magnetization-prepared rapid gradient echo), T2-weighted, T1-weighted, and diffusion tensor image sequences were obtained at 0° (relative to the anterior commissure-posterior commissure line). The images were again transferred into the frame-link software workstation.

The frame-link software was used to merge the CT and MR images automatically and calculate the stereotactic cube. The merged images were then reviewed very carefully for any inaccuracies; particular attention was paid to the anatomical fit of the ventricles and the surface skin fiducials.

The stereotactic frame localizer was automatically recognized and identified by the frame-link software and an average transformation error was displayed. I accepted a transformation error < 0.6 mm. The middle point of the anterior commissure and the posterior commissure was identified manually and stored digitally. An additional 3 midline points were then manually identified and stored to correct for any residual tilt, yaw, or rotation of the brain.

The target was then manually identified by measuring 20 mm posterior to the tip of the ipsilateral frontal horn in the sagittal images, 7 mm from the midline in the coronal images, and 1 mm above the roof of the lateral ventricle using both sagittal and coronal images. The x, y, and z stereotactic coordinates of these 2 targets were obtained.

Operation

The stereotactic frame reference ring was fixed to the operating table in the operating room, using a modified connection to the Mayfield head fixation system. The patient’s head was slightly flexed forward and elevated to 30°. The scalp was prepared by shaving a very small area where the scalp incisions were to be made, 1.5 cm on either side of the midline and just in front of the coronal suture. The scalp was cleansed with antiseptic iodine solution. Before the scalp preparation the anesthetist gave 1.5 g of cefuroxime intravenously. The stereotactic coordinates of the right-side target were translated into the stereotactic frame-aiming bow, which was fixed to the stereotactic frame reference ring. Surgical draping of the operative field was completed, making sure that access to the aiming bow mechanism to translate the stereotactic coordinates of the left-side target was not obscured by the drapes.

Two small (2-cm) scalp incisions were made and a small bur hole was made on either side. A radiofrequency probe with a 6-mm-long, 3-mm-wide exposed tip (Integra Radionics) was connected to a radiofrequency lesion generator (Integra Radionics) and positioned in the right-side target. The probe tip was heated to 70°C for 90 seconds; this procedure was repeated twice to produce a lesion of 8 × 8 mm.

The stereotactic coordinates of the left-side target were then translated onto the stereotactic frame-aiming bow and the same procedure repeated to produce a lesion on the left side.

The aponeurosis and skin layers of the scalp were sutured by 3-0 Vicryl suture (Ethicon, Inc.), and the incisions were glued using Dermabond (Ethicon, Inc.).

Postoperative Care

Patients were cared for in the recovery room until they were fully awake from anesthesia, then observed in the high-dependency unit overnight before being transferred to the ward. The average length of stay in the neurosurgical unit was 3 days. The average stay in the psychiatric unit varied from patient to patient depending on the number of postoperative tests required and the distance the patient had to travel from his or her town of residence to the unit.

Magnetic resonance imaging was performed to confirm positions and sizes of the lesions during the 1st week following surgery (Figs. 2 and 3). Patients underwent psychiatric testing similar to that administered preoperatively. They were followed up by members of the psychiatric staff and received therapy as needed. Follow-up MR imaging was performed at 12 months after surgery (Fig. 4).



View larger version (25K)

Fig. 2 Coronal T2-weighted MR image obtained during the 1st week after BACI.





View larger version (36K)

Fig. 3 A diffusion tensor image showing the BACI lesions.





View larger version (67K)

Fig. 4 Coronal T2-weighted MR image obtained 12 months after BACI.



Bilateral Anterior Capsulotomy

Bilateral anterior capsulotomy refers to stereotactic ablation of the most anterior portion of the anterior limb of the internal capsule lateral to the head of the caudate nucleus, the white matter bundle connecting the frontal and the anterior cingulate cortex with the thalamus, the hippocampus, and the amygdala. The procedure was first described by Talairach et al. in 194934 and was later modified by Lars Leksell for the treatment of chronic pain.19

Preparation and Planning

The steps involved in preparation of the patient and planning of the procedure were exactly the same for BACA as those described under BACI except that the targets were different. The targets were the anterior third of the anterior limb of the internal capsule lateral to the head of the caudate nucleus on either side of the brain. They were contoured using the frame-link software starting as caudally as possible and extending to the rostral level of the head of the caudate. The trajectories were chosen by drawing a line from the center of the most inferior part of the contoured target to the center of the top of the target on either side, and the 2 lines were extended toward the skull surface. The intersection of the 2 lines with the outer surface of the skull marked the site of the entry point on either side. The x, y, and z stereotactic coordinates and the 2 trajectory angles of these 2 targets were obtained.

Operation

Transfer of the patient to the operating table, head fixation, scalp preparation, antibiotic prophylaxis, and bur-hole formation followed steps similar to those described above under BACI. A radiofrequency probe with a 6-mm-long, 3-mm-wide exposed tip was connected to the radiofrequency lesion generator (both from Integra Radionics) and positioned so that its tip lay in the most caudal part of the contoured right target. The probe tip was heated to 70°C for 90 seconds. The probe was then withdrawn 6 mm and another lesion was made in the same fashion to produce a lesion 8 mm wide and 12 mm long along the contoured right target. The stereotactic coordinates and trajectory angles for the left target were then translated onto the stereotactic frame reference ring and the same procedure was repeated to produce the lesion on the contoured left target.

The aponeurosis and skin layers of the scalp were closed as in BACI.

Postoperative Care

Patients were cared for similarly to those who underwent BACI. As in the cases in which patients were treated with BACI, follow-up MR imaging was performed 12 months postoperatively (Fig. 5).



View larger version (71K)

Fig. 5 Coronal T2-weighted MR image obtained 12 months after BACA.



Outcome Assessment

Depression was considered in remission in patients who scored 7 on the HRSD-17 or 10 on the Montgomery-Åsberg Depression Rating Scale (MADRS).17,24 Treatment response was defined by reduction in baseline HRSD-17 or MADRS score of 50% or a CGI-I (Clinical Global Impression)29 score of 1 or 2. Neurocognitive performance was assessed using a standard battery of clinical tests focusing on executive function and the Cambridge Neuropsychological Test Automated Battery (CANTAB, www.cantabeclipse.com).


Results

Twelve-month follow-up data were available for 25 of 30 patients with TRD. The mean age (standard deviation) was 43 ± 9.8 years; 22 of these 25 patients were women, and 43.3% were inpatients at the time of surgery. The mean duration of illness was 10.5 years with a mean total duration of hospitalization of 2.5 years. The mean number of adequate treatment trials was 9.1 ± 3.2. The 12-month response rates for BACA and BACI were 25 and 60%, respectively. The remission rate was 10% (2 of 20 patients) for BACA and 20% (1 of 5 patients) for BACI. Longer-term remission rates were similar following both procedures at 40%, but the numbers of patients for whom longer-term follow-up data were available are too small to allow for generalization.

Minor transient adverse events were recorded as follows: headache in 15 patients (4 who underwent BACI and 11 who underwent BACA), nausea in 5 (4, BACI; 1, BACA), dizziness in 2 (1 in each treatment category), incontinence in 4 (1, BACI; 3, BACA), confusion in 6 (all BACA), and facial swelling in 5 (3, BACI; 2, BACA). Serious adverse events included epilepsy in 1 patient following BACI and 1 intracerebral hemorrhage leading to permanent hemi-paresis following BACA.

More detailed results of the service are beyond the scope of this paper and were published extensively elsewhere.22,31


Discussion

Ablative procedures for mental disorders continue to be provided on a small scale worldwide to help those who have not responded to nonsurgical therapies. In recent years a group of researchers from Boston reported the 12-month outcomes for 13 patients with severe TRD who were treated by means of BACI.8,28 Functional brain imaging was performed pre- and postoperatively to look for changes predictive of a positive response to BACI.8 At 12 months after the procedure, 38.5% of the patients demonstrated a 50% or greater reduction in depression symptom scores. The results of functional imaging suggested that elevated preoperative metabolism in the left subgenual prefrontal cortex (Area 25) and left thalamus was associated with superior outcome following BACI. Another group reported the outcomes from a prospective audit of BACA for 15 patients with OCD.27 The authors concluded that outcomes were generally favorable, but not all data were available for every patient. The response rate after BACA in Dundee was 25% and the remission rate was 10%, compared with a 60% response rate and a 20% remission rate after BACI in TRD. Due to the perceived better response rate of TRD patients after BACI and the perceived lower complication rate of BACI compared with BACA, after consulting with my psychiatric colleagues I have shifted the procedure of preference in TRD to BACI and have not performed BACA for the treatment of TRD since 2000.

Nonablative procedures such as VNS represent a very attractive option. Vagus nerve stimulation entails no risk of permananet neurological or intracranial complications and does not damage brain tissue. The clinical results of VNS in 205 patients with TRD were reported after 9 and 12 months of unblinded, active treatment.30 For the total group, the response rate (defined as a 50% drop in HRSD score) after 12 months of VNS was 27.2%, with a remission rate (sustained 24-item HRSD score > 10) of 15.8%. Of note, the severity of TRD in these patients was much less than that reported in patients undergoing BACI and BACA at our center as well as that reported by other researchers.8 The response and remission rates following VNS were significantly lower than the Dundee experience with BACI despite the fact that the illness was more protracted in our patients. Nevertheless, the attraction of VNS is the absence of permanaent neurological deficit arising from intracranial complications of permanent neural tissue ablation. Severe adverse effects from VNS were very low in comparison to BACI or BACA. However, 14.6% of patients treated by means of VNS experienced worsening of their depression severe enough to require hospitalization during the year. The most common adverse effects directly related to stimulation included voice alteration (54%), which was expected. However, breathlessness occurred in 16%, neck pain in 13%, and cough in 5%. There were 3 deaths in this case series, one of which was by suicide after 5 weeks of VNS. The results of chronic VNS in TRD are favorable when compared to continuing TRD treatment as usual, where only 13% met the criteria for response and only 3% went into remisson in 12 months.16

More recently, several groups published their experience with DBS in TRD and OCD.1,3,4,12,15,18,23,26 The reported outcome of DBS therapy compares favorably to that reported following BACI and BACA. Mayberg et al.23 reported on a series of 6 patients with TRD who were treated with Area 25 DBS. The criteria for response were fulfilled in 4 (66%) of the 6 cases and the criteria for remission in 2 (33%). These results compared very well with the 60% response and 20% remission rates we experienced with BACI. However, TRD and OCD in patients treated with DBS were not as protracted as they were in patients treated with BACI and BACA in Dundee. It is also important to point out that DBS therapy in OCD and TRD is more expensive than treatment with BACI or BACA, due to the continuing costs of programming, hardware failure, and battery changes.27 Although the complication rates of DBS therapy are likely to be less than those attributed to BACI and BACA, the reported complications are not insignificant7,35 and include an infection rate of 6%, a short-term (24-month) hardware failure rate of 1.4%,7 and a long-term failure rate of 26%.20 Furthermore, DBS implantation precludes any future treatment with ECT. However, DBS therapy for OCD and TRD is here to stay and is likely to replace ablative procedures as the targets become more defined and the outcome of DBS improves. There are compelling reasons for embracing VNS and DBS therapy: lack of intended brain destruction, as well as reversibility and flexibility of stimulation.


Conclusions

In appropriately selected patients, BACI, BACA, VNS, and DBS therapies provide significant improvement. Both BACI and BACA are relatively safe and when performed by a multidisciplinary team can offer good outcome for many patients who otherwise would be denied the chance of enjoying a better life. However, if the choice were based on the perceived risk of irreversible brain damage or the risk of permanent neurological deficit, VNS would come first, DBS second, BACI third, and finally BACA.


Acknowledgments

I would like to acknowledge the contribution of Keith Mathews, David Christmas, and the late George Fenton for selecting these patients and providing the psychiatric component of the service; the Mental Care Commission for Scotland for providing independent assessments for these patients; Mr. T. R. K. Varma for starting the programme; and the MR imaging staff, neurosurgical operating theater staff, neurosurgical ward staff, the psychiatric unit staff, and Dr. Praveen Manthri (neurosurgical anesthetist) for their contributions to the service; and Jim Crosby, Mark Tulley, and Partick Carina for technical support.


References
1. Abelson JL, ­ Curtis GC, ­ Sagher O, ­ Albucher RC, ­ Harrigan M, ­ Taylor SF, ­et al.: Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry 57:510–516, 2005
2. Alterman RL, ­ Sterio D, ­ Beric A, ­ Kelly PJ: ­ Microelectrode recording during posteroventral pallidotomy: impact on target selection and complications. Neurosurgery 44:315–323, 1999
3. Anderson D, ­ Ahmed A: ­ Treatment of patients with intractable obsessive-compulsive disorder with anterior capsular stimulation. Case report. J Neurosurg 98:1104–1108, 2003
4. Aouizerate B, ­ Cuny E, ­ Martin-Guehl C, ­ Guehl D, ­ Amieva H, ­ Benazzouz A, ­et al.: Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg 101:682–686, 2004
5. Bernard PG, ­ Ballantine HT, ­ Giriunan L: ­ Neuropathological study of bilateral cingulotomy for mood disturbance, in Hitchcock ER, Ballantine HT, Meyerson BA (eds): Modern Concepts in Psychiatric Surgery. New York: Elsevier, 1979, pp 283–302
6. Bush G, ­ Luu P, ­ Posner MI: ­ Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4:215–222, 2000
7. Constantoyannis C, ­ Berk C, ­ Honey CR, ­ Mendez I, ­ Brownstone RM: ­ Reducing hardware-related complications of deep brain stimulation. Can J Neurol Sci 32:194–200, 2005
8. Dougherty DD, ­ Weiss A, ­ Cosgrove GR, ­ Alpert NM, ­ Cassem EH, ­ Nierenberg AA, ­et al.: Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg 99:1010–1017, 2003
9. Drevets WC: ­ Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 126:413–431, 2000
10. Eljamel MS: ­ Validation of the PathFinder neurosurgical robot using a phantom. Int J Med Robot 3:372–377, 2007
11. Eljamel MS, ­ Forster A, ­ Tulley M, ­ Matthews K: ­ Staged functional neurosurgery using image fusion: electronic atlas and microelectrode recording at Dundee. Stereotact Funct Neurosurg 73: 140–142, 1999
12. Eljamel MS, ­ Hofer M: ­ From letterbox to keyhole approach for resecting intracranial lesions. Stereotact Funct Neurosurg 81: 30–36, 2003
13. Eljamel MS, ­ Tulley M, ­ Spillane K: ­ A simple stereotactic method for frameless deep brain stimulation. Stereotact Funct Neurosurg 85:6–10, 2007
14. Foltz EL, ­ White LE Jr: ­ Pain “relief” by frontal cingulumotomy. J Neurosurg 19:89–100, 1962
15. Gabriëls L, ­ Cosyns P, ­ Nuttin B, ­ Demeulemeester H, ­ Gybels J: ­ Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiat Scand 107:275–282, 2003
16. George MS, ­ Rush AJ, ­ Marangell LA, ­ Sackeim HA, ­ Brannan SK, ­ Davis SM, ­et al.: A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiat 58:364–373, 2005
17. Hamilton M: ­ A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62, 1960
18. Jimenez F, ­ Velasco F, ­ Salin-Pascual R, ­ Hernandez JA, ­ Velasco M, ­ Criales JL, ­et al.: Patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery 57:585–593, 2005
19. Leksell L: ­ Sterotaxic radiosurgery in trigeminal neuralgia. Acta Chir Scand 137:311–314, 1971
20. Lyons KE, ­ Wilkinson SB, ­ Overman J, ­ Pahwa R: ­ Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures. Neurology 63:612–616, 2004
21. Maciunas RJ, ­ Galloway RL Jr, ­ Latimer JW: ­ The application accuracy of stereotactic frames. Neurosurgery 35:682–695, 1994
22. Matthews K, ­ Eljamel MS: ­ Status of neurosurgery for mental disorder in Scotland. Selective literature review and overview of current clinical activity. Br J Psychiatry 182:404–411, 2003
23. Mayberg HS, ­ Lozano AM, ­ Voon V, ­ McNeely HE, ­ Seminowicz D, ­ Hamani C, ­et al.: Deep brain stimulation for treatment-resistant depression. Neuron 45:651–660, 2005
24. Montgomery SA, ­ Åsberg M: ­ A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389, 1979
25. Mufson EJ, ­ Pandya DN: ­ Some observations on the course and composition of the cingulum bundle in the rhesus monkey. J Comp Neurol 225:31–43, 1984
26. Nuttin BJ, ­ Gabriëls LA, ­ Cosyns PR, ­ Meyerson BA, ­ Andréewitch S, ­ Sunaert SG, ­et al.: Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery 52:1263–1274, 2003
27. Okun MS, ­ Tagliati M, ­ Pourfar M, ­ Fernandez HH, ­ Rodriguez RL, ­ Alterman RL, ­et al.: Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 62:1250–1255, 2005
28. Oliver B, ­ Gascón J, ­ Aparicio A, ­ Ayats E, ­ Rodriguez R, ­ Maestro de León JL, ­et al.: Bilateral anterior capsulotomy for refractory obsessive-compulsive disorders. Stereotactact Funct Neurosurg 81:90–95, 2003
29. Oliver J, ­ Huxley P, ­ Bridges K, ­ Mohamad H: ­ Quality of Life and Mental Health Services. London: Routledge, 1996
30. Rush AJ, ­ Sackeim HA, ­ Marangell LB, ­ George MS, ­ Brannan SK, ­ Davis SM, ­et al.: Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 58:355–363, 2005
31. Steele JD, ­ Christmas D, ­ Eljamel MS, ­ Matthews K: ­ Anterior cingulotomy for major depression: clinical outcome and relationship to lesion characteristics. Biol Psychiatry 63:670–677, 2008
32. Steele JD, ­ Currie J, ­ Lawrie SM, ­ Reid I: ­ Prefrontal cortical functional abnormality in major depressive disorder: a stereotactic meta-analysis. J Affect Disord 101:1–11, 2007
33. Steele JD, ­ Lawrie SM: ­ Segregation of cognitive and emotional function in the prefrontal cortex: a stereotactic meta-analysis. Neuroimage 21:868–875, 2004
34. Talairach J, ­ Hecaen H, ­ David M: ­ Lobotomie prefrontale limitee par electrocoagulation des fibres thalamo-frontalis leur emergence du bras anterior de la capsule interne, in Proceedings of the 4th Congress Neurologique Internationale. Paris: Masson, 1949, p 141
35. Umemura A, ­ Jaggi JL, ­ Hurtig HI, ­ Siderowf AD, ­ Colcher A, ­ Stern MB, ­et al.: Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg 98:779–784, 2003
36. Yen CP, ­ Kung SS, ­ Su YF, ­ Lin WC, ­ Howng SL, ­ Kwan AL: ­ Stereotactic bilateral anterior cingulotomy for intractable pain. J Clin Neurosci 12:886–890, 2005